Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

29-Apr-19 - 28-Jul-19
Buy Ratio:35%


# Net Buyers:60
# Net Sellers:113

Previous 13 Weeks

28-Jan-19 - 28-Apr-19
Buy Ratio:27%
# Net Buyers:52
# Net Sellers:143
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Loxo Oncology, Inc.--$561.91M  
Osiris Therapeutics, Inc.--$281.65M  
Spark Therapeutics, Inc.($283.91K)$254.96M  
Eli Lilly & Co($1.80M)$112.90M  
Pfizer Inc($8.07M)$103.75M  
New Net Buyers
CompanyNet Buy AmountChange
Galectin Therapeutics Inc$20.20M$20.29M  
Johnson & Johnson$419.04K$20.00M  
Bristol Myers Squibb Co$447.72K$17.40M  
Intercept Pharmaceuticals, Inc.$9.62M$14.70M  
Catalent, Inc.$2.59M$9.01M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Alexion Pharmaceuticals, Inc.($38.77M)($34.62M)  
Alder Biopharmaceuticals Inc--($19.84M)  
Dicerna Pharmaceuticals Inc($20.00M)($19.78M)  
Neurocrine Biosciences Inc($16.95M)($14.40M)  
Amyris, Inc.$4.88M($13.65M)  
New Net Sellers
CompanyNet Buy AmountChange
Pacira Biosciences, Inc.($2.58M)($2.64M)  
Bausch Health Companies Inc.($165.88K)($2.40M)  
Novus Therapeutics, Inc.($57.47K)($2.06M)  
Epizyme, Inc.($1.34M)($1.38M)  
Cumberland Pharmaceuticals Inc($329.85K)($995.04K)